Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Duke Street is a leading UK-based private equity firm focused on leveraged buyouts and growth capital investments in mid-market Western European businesses. It has invested over €2.5 billion in more than 50 companies since inception and has achieved strong returns exceeding a 20% IRR. The firm's healthcare investments include medical device manufacturers and healthcare service providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Duke Street Capital Limited.